On February 18, 2021 PCI Biotech’s (OSE: PCIB) reported that fourth quarter and preliminary full year 2020 interim report will be released on 24 February 2021 at 07.00 CET (Press release, PCI Biotech, FEB 18, 2021, View Source [SID1234585155]). The interim report and presentation will be made available on www.newsweb.no and on the company’s webpage, www.pcibiotech.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A results presentation (in English) will be held through a live webcast at 08.30 CET the same day. The webcast can be accessed through www.pcibiotech.com. There will be a Q&A session at the end of the presentation. It will be possible to post written questions through the webcast console or through a teleconference facilitated for investors intending to ask questions verbally during the Q&A session.